Apellis Pharmaceuticals
APLS
APLS
262 hedge funds and large institutions have $4.43B invested in Apellis Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 126 increasing their positions, 66 reducing their positions, and 66 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
33% less capital invested
Capital invested by funds: $6.65B → $4.43B (-$2.22B)
38% less funds holding in top 10
Funds holding in top 10: 8 → 5 (-3)
52% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 66
Holders
262
Holding in Top 10
5
Calls
$230M
Puts
$50M
Top Buyers
| 1 | +$57.5M | |
| 2 | +$51M | |
| 3 | +$47.5M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$43M |
| 5 |
JPMorgan Chase & Co
New York
|
+$36.9M |
Top Sellers
| 1 | -$52M | |
| 2 | -$49.4M | |
| 3 | -$45.4M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$39.6M |
| 5 |
ITP
Iron Triangle Partners
Cos Cob,
Connecticut
|
-$32.3M |